http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111273030-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17975b76948769046f8ca37ce9651781 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-485 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54306 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-581 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate | 2020-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5734fb37fdccb0d693c2394af924f6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ede952a2140cc6d718fa5adc86e325f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93a62dff0165be7833bf17f62e228beb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03c5851ddcf15e45aa7391217846a0e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37199bbf8221ace032cd86b2ec7796c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_806626caffe46745d7a5e104d2a966b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d8fe64c3e49ada5e4464a3f31bbe750 |
| publicationDate | 2020-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111273030-A |
| titleOfInvention | A direct competition ELISA kit for quantitative detection of recombinant human epidermal growth factor and its application |
| abstract | The invention discloses a direct competition ELISA kit for quantitative detection of recombinant human epidermal growth factor and its application, including a microporous enzyme label plate coated with a recombinant human epidermal growth factor polyclonal antibody, a recombinant human epidermal growth factor standard, and an enzyme marker Recombinant human epidermal growth factor antigen, chromogenic solutions A and B, 20X concentrated wash solution, sample diluent and stop solution. Through antigen-antibody specific reaction, based on enzyme immune technology, a direct competitive ELISA method was established and developed to quantitatively detect recombinant human epidermal growth factor in fermentation broth, semi-finished products, finished products, etc. and clinical tissue cell samples. Methodology and commercialization The kit can be used for the development of corresponding products and the specific detection of clinical samples; the minimum detection limit of the method of the invention can reach 2.0ng/ml, the intra-batch difference is less than 5%, and the inter-batch difference is less than 10%; the recovery rate is 90% % to 110%, indicating that the kit has important commercial development value for manufacturers to control product quality and detect clinical specimens. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115097129-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115097129-A |
| priorityDate | 2020-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.